INOVIO PHARMACEUTICALS, INC. short interest in 2025
In 2025, INOVIO PHARMACEUTICALS, INC.'s disclosed short interest ran from 18.74% of shares outstanding on 15 Jan 2025 to 18.42% on 31 Dec 2025, a change of -0.32 percentage points. The year's high was 21.16% on 28 Feb 2025 and its low 10.60% on 15 Aug 2025, averaging 16.51% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.90 days on 30 Apr 2025. Full history: INOVIO PHARMACEUTICALS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 18.74% (15 Jan 2025)
- End of year
- 18.42% (31 Dec 2025)
- Change
- -0.32 pp
- High
- 21.16% (28 Feb 2025)
- Low
- 10.60% (15 Aug 2025)
- Average
- 16.51%
- Highest days to cover
- 15.90 (30 Apr 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 18.74% | 3.20 | |
| 31 Jan 2025 | 19.19% | 6.23 | |
| 14 Feb 2025 | 20.63% | 8.39 | |
| 28 Feb 2025 | 21.16% | 7.13 | |
| 14 Mar 2025 | 14.60% | 10.77 | |
| 31 Mar 2025 | 17.45% | 7.08 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 18.22% | 8.55 | |
| 30 Apr 2025 | 17.63% | 15.90 | |
| 15 May 2025 | 19.12% | 13.39 | 10-Q filed, results (8-K) |
| 30 May 2025 | 17.91% | 10.87 | |
| 13 Jun 2025 | 17.62% | 8.43 | |
| 30 Jun 2025 | 15.00% | 5.23 | |
| 15 Jul 2025 | 16.33% | 1.19 | |
| 31 Jul 2025 | 13.90% | 3.37 | |
| 15 Aug 2025 | 10.60% | 2.62 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 12.41% | 2.91 | |
| 15 Sep 2025 | 14.10% | 3.61 | |
| 30 Sep 2025 | 14.35% | 8.19 | |
| 15 Oct 2025 | 14.26% | 7.53 | |
| 31 Oct 2025 | 15.45% | 8.00 | |
| 14 Nov 2025 | 15.42% | 4.89 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 16.11% | 8.63 | |
| 15 Dec 2025 | 17.63% | 7.74 | |
| 31 Dec 2025 | 18.42% | 4.36 |
See also: INOVIO PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.